Linfeng Xu

929 total citations
58 papers, 617 citations indexed

About

Linfeng Xu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Linfeng Xu has authored 58 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 27 papers in Molecular Biology and 18 papers in Surgery. Recurrent topics in Linfeng Xu's work include Renal cell carcinoma treatment (15 papers), Bladder and Urothelial Cancer Treatments (13 papers) and Renal and related cancers (13 papers). Linfeng Xu is often cited by papers focused on Renal cell carcinoma treatment (15 papers), Bladder and Urothelial Cancer Treatments (13 papers) and Renal and related cancers (13 papers). Linfeng Xu collaborates with scholars based in China, United States and Italy. Linfeng Xu's co-authors include Hongqian Guo, Xuefeng Qiu, Xiaozhi Zhao, Xiaogong Li, Rong Yang, Huibo Lian, Yuanzhi Lao, Hong‐Xi Xu, Weidong Gan and Weidong Gan and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of Power Sources.

In The Last Decade

Linfeng Xu

55 papers receiving 613 citations

Peers

Linfeng Xu
Anna Kulidjian United States
Zhengwang Sun China
Huibo Lian China
Harley Francisco de Oliveira Brazil
Hye Jin Jang South Korea
Tao Guo China
Zhuojun Zhang China
Yuanyuan Xu China
Mariana Scaranti Brazil
Andre R. Jordan United States
Anna Kulidjian United States
Linfeng Xu
Citations per year, relative to Linfeng Xu Linfeng Xu (= 1×) peers Anna Kulidjian

Countries citing papers authored by Linfeng Xu

Since Specialization
Citations

This map shows the geographic impact of Linfeng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linfeng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linfeng Xu more than expected).

Fields of papers citing papers by Linfeng Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linfeng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linfeng Xu. The network helps show where Linfeng Xu may publish in the future.

Co-authorship network of co-authors of Linfeng Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Linfeng Xu. A scholar is included among the top collaborators of Linfeng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linfeng Xu. Linfeng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ren, Meng, et al.. (2025). Sulfate-mediated enhancement of simultaneous nitrate and hexavalent chromium removal in Fe(0)-based autotrophic bioprocesses. Journal of environmental chemical engineering. 13(5). 118580–118580.
2.
Xu, Linfeng, et al.. (2025). Impacts of key physical parameters on the cycling of thin metallic lithium in sulfide-based all-solid-state batteries. Journal of Power Sources. 655. 237999–237999. 4 indexed citations
3.
Huang, Juehao, Linfeng Xu, Yuefeng Qiu, et al.. (2025). Deformation Behaviors of Soft Clay under Cyclic Confining Pressures with Composite Loading Frequencies. International Journal of Geomechanics. 25(6). 1 indexed citations
4.
Zhang, Xuyu, Feng Zhou, Shun Zhang, et al.. (2025). Neoadjuvant darolutamide plus androgen deprivation therapy for high-risk and locally advanced prostate cancer: a multicenter, open-label, single-arm, phase II trial. World Journal of Urology. 43(1). 58–58. 1 indexed citations
5.
Fu, Yao, Giancarlo Marra, Feifei Zhang, et al.. (2024). Modified Retzius-sparing robot-assisted radical prostatectomy for cases with anterior tumor: a propensity score-matched analysis. World Journal of Urology. 42(1). 170–170.
6.
Xu, Linfeng, Xingxing Jian, Jian Ouyang, et al.. (2023). PGNneo: A Proteogenomics-Based Neoantigen Prediction Pipeline in Noncoding Regions. Cells. 12(5). 782–782. 14 indexed citations
7.
Peng, Wei, Zhe Zhang, Zhenwei Wu, et al.. (2023). Abstract 3089: XNW5004: a novel EZH2 inhibitor efficacious in multiple cancer xenograft models as a single agent and in combination studies. Cancer Research. 83(7_Supplement). 3089–3089. 1 indexed citations
8.
9.
Jian, Xingxing, Linfeng Xu, Jingjing Zhao, et al.. (2022). NAIRscore as a biomarker for the quality of immune response to neoantigens is related with an increased overall survival in multiple myeloma. Molecular Therapy — Nucleic Acids. 29. 285–295. 6 indexed citations
10.
Zhuang, Junlong, Yansheng Kan, Yuwen Wang, et al.. (2022). Machine Learning-Based Prediction of Pathological Upgrade From Combined Transperineal Systematic and MRI-Targeted Prostate Biopsy to Final Pathology: A Multicenter Retrospective Study. Frontiers in Oncology. 12. 785684–785684. 3 indexed citations
11.
Lu, Manman, Linfeng Xu, Xingxing Jian, et al.. (2022). dbPepNeo2.0: A Database for Human Tumor Neoantigen Peptides From Mass Spectrometry and TCR Recognition. Frontiers in Immunology. 13. 855976–855976. 23 indexed citations
12.
Ma, Wenliang, Ning Liu, Weijian Li, et al.. (2020). Comparative Clinicopathologic Characteristics and Outcomes of Paediatric and Adult Xp11 Translocation Renal Cell Carcinomas: a Retrospective Multicentre Study in China. Scientific Reports. 10(1). 2249–2249. 11 indexed citations
13.
Hua, Lei, et al.. (2019). Nucleolar spindle associated protein 1 (NUSAP1) facilitates proliferation of hepatocellular carcinoma cells. Translational Cancer Research. 8(5). 2113–2120. 2 indexed citations
14.
Yuan, Man, Linfeng Xu, Juan Zhang, et al.. (2019). SRC and MEK Co-inhibition Synergistically Enhances the Anti-tumor Effect in Both Non-small-cell Lung Cancer (NSCLC) and Erlotinib-Resistant NSCLC. Frontiers in Oncology. 9. 586–586. 19 indexed citations
15.
16.
Gan, Weidong, Feng Qu, Zhen Wang, et al.. (2018). Does the Fuhrman or World Health Organization/International Society of Urological Pathology Grading System Apply to the Xp11.2 Translocation Renal Cell Carcinoma?. American Journal Of Pathology. 188(4). 929–936. 8 indexed citations
17.
Xu, Linfeng, Xiaoxiao Meng, Naihan Xu, et al.. (2018). Gambogenic acid inhibits fibroblast growth factor receptor signaling pathway in erlotinib-resistant non-small-cell lung cancer and suppresses patient-derived xenograft growth. Cell Death and Disease. 9(3). 262–262. 42 indexed citations
18.
Xu, Linfeng, Xuefeng Qiu, Yanting Zhang, et al.. (2016). Liposome encapsulated perfluorohexane enhances radiotherapy in mice without additional oxygen supply. Journal of Translational Medicine. 14(1). 268–268. 25 indexed citations
19.
Xu, Linfeng, Rong Yang, Wei Wang, Yifen Zhang, & Weidong Gan. (2014). Laparoscopic radiofrequency ablation-assisted enucleation of Xp11.2 translocation renal cell carcinoma: A case report. Oncology Letters. 8(3). 1237–1239. 3 indexed citations
20.
Mao, Yuan, Dawei Zhang, Huijun Zhu, et al.. (2012). LMP1 and LMP2A are potential prognostic markers of extranodal NK/T-cell lymphoma, nasal type (ENKTL). Diagnostic Pathology. 7(1). 178–178. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Kulidjian Breakdown of academic impact, for papers by Zhengwang Sun Breakdown of academic impact, for papers by Huibo Lian Breakdown of academic impact, for papers by Harley Francisco de Oliveira Breakdown of academic impact, for papers by Hye Jin Jang Breakdown of academic impact, for papers by Tao Guo Breakdown of academic impact, for papers by Zhuojun Zhang Breakdown of academic impact, for papers by Yuanyuan Xu Breakdown of academic impact, for papers by Mariana Scaranti Breakdown of academic impact, for papers by Andre R. Jordan
Rankless by CCL
2026